This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| celiac disease | |
|---|---|
| Name | Celiac disease |
| Field | Gastroenterology, Immunology |
| Symptoms | Diarrhea, weight loss, anemia, fatigue |
| Complications | Malnutrition, osteoporosis, lymphoma |
| Onset | Any age |
| Duration | Chronic |
| Causes | Autoimmune reaction to gluten |
| Risks | Family history, HLA-DQ2, HLA-DQ8 |
| Diagnosis | Serologic testing, intestinal biopsy |
| Treatment | Gluten-free diet |
celiac disease is an immune-mediated enteropathy triggered by dietary gluten in genetically susceptible individuals. It produces malabsorption, systemic manifestations, and increased risk of complications when untreated. Clinical recognition, serologic testing, and histologic confirmation guide management, which centers on lifelong dietary modification and monitoring.
Classical presentations include chronic diarrhea, steatorrhea, weight loss, and failure to thrive, commonly recognized alongside abdominal pain, bloating, and flatulence in children and adults. Extraintestinal features often prompt evaluation and include iron-deficiency anemia, chronic fatigue, osteoporosis and osteopenia, dermatitis herpetiformis, short stature, delayed puberty, and neurologic manifestations such as ataxia and peripheral neuropathy. Associations have been described with autoimmune conditions and systemic disorders, so patients may present with thyroid dysfunction, type 1 diabetes mellitus, elevated liver enzymes, reproductive problems such as infertility and recurrent miscarriage, or psychiatric comorbidity including depression and anxiety. Dermatitis herpetiformis presents with pruritic vesicles and is linked to cutaneous immunopathology. Signs of malnutrition and micronutrient deficiencies—folate, vitamin B12, vitamin D, calcium, iron—are common, and refractory cases may progress to enteropathy-associated T-cell lymphoma, small bowel adenocarcinoma, or hyposplenism with increased infection risk.
Pathogenesis requires ingestion of gluten proteins from wheat, barley, and rye in individuals carrying HLA-DQ2 or HLA-DQ8 haplotypes, provoking a maladaptive immune response in the small intestinal mucosa. Tissue transglutaminase modifies gliadin peptides, increasing their affinity for antigen-presenting cells and promoting CD4+ T-cell activation in the lamina propria, leading to cytokine-mediated villous atrophy, crypt hyperplasia, and intraepithelial lymphocytosis. Both adaptive and innate immune mechanisms are implicated, with B-cell production of anti-tissue transglutaminase and anti-deamidated gliadin peptide antibodies serving as disease biomarkers. Genetic predisposition involves HLA loci and non-HLA loci influencing immune regulation; environmental factors such as timing of gluten introduction, viral exposures, and intestinal microbiota composition may modulate risk and phenotypic expression. Mucosal damage impairs nutrient absorption and alters gut barrier function, contributing to systemic manifestations and autoimmunity via molecular mimicry and bystander activation.
Evaluation integrates clinical suspicion with serologic testing and histologic confirmation. Recommended first-line serologies include IgA anti-tissue transglutaminase and total serum IgA to detect selective IgA deficiency; anti-deamidated gliadin peptide assays provide adjunctive sensitivity, particularly in children and IgA-deficient individuals. Positive serology typically prompts upper endoscopy with duodenal biopsies demonstrating villous atrophy, crypt hyperplasia, and increased intraepithelial lymphocytes to confirm diagnosis. HLA-DQ2/DQ8 typing has high negative predictive value and is useful to exclude disease when serology and histology are inconclusive or when patients have initiated a gluten-free diet before testing. Noninvasive approaches and guidelines differ by region and age group; pediatric criteria in some jurisdictions allow diagnosis without biopsy in selected high-probability cases with markedly elevated serology and specialist confirmation. Differential diagnosis includes tropical sprue, autoimmune enteropathy, giardiasis, common variable immunodeficiency, Crohn disease, and medication-related villous injury.
The cornerstone of therapy is a strict, lifelong gluten-free diet excluding wheat, barley, rye, and contaminated oats for many patients, combined with patient education and dietitian support. Nutritional rehabilitation addresses iron, folate, vitamin D, calcium, and B12 deficiencies; bone density assessment and osteoporosis management are indicated when appropriate. Refractory celiac disease, defined by persistent villous atrophy despite adherence, requires evaluation for adherence, alternative diagnoses, and complications; immunosuppressive agents such as corticosteroids, azathioprine, or biologics may be used in refractory cases or overt enteropathy-associated T-cell lymphoma under specialist care. Dermatitis herpetiformis responds to dapsone for symptomatic control alongside dietary measures. Emerging therapies under investigation include enzymatic gluten degradation, zonulin pathway modulators to reduce intestinal permeability, peptide-based immunotherapy, and vaccines aiming to induce tolerance, but none have yet replaced dietary treatment as standard of care. Regular follow-up includes symptom assessment, serologic monitoring, bone health evaluation, and cancer surveillance in high-risk patients.
Prevalence estimates vary worldwide but are commonly reported near 1% in many populations, with higher detection in regions with widespread screening and awareness. Seroprevalence and clinically diagnosed rates differ by country and by population subgroup; genetic predisposition is common, yet penetrance is incomplete, resulting in many undiagnosed or atypical cases. Incidence peaks vary with age, occurring in childhood and again in adulthood, and rising recognition has paralleled improved diagnostic capability. Geographic variation aligns with HLA allele distribution and dietary patterns, while disparities in access to specialist care and diagnostic testing influence reported rates. Familial clustering and association with other autoimmune diseases increase individual risk; population screening strategies remain debated due to variable benefit, resource considerations, and the importance of confirming diagnosis before initiating treatment.
Descriptions of gluten-associated enteropathy date back to antiquity and were refined through 19th- and 20th-century clinical observation, pathologic characterization, and dietary experiments that identified wheat-associated factors. Landmark contributions included clinical reports by physicians identifying malabsorptive syndromes, the role of dietary exclusion in symptomatic improvement, and the later discovery of tissue transglutaminase autoantibodies as diagnostic markers. Public health impact includes advocacy for labeling regulations, development of gluten-free food industries, and patient organizations promoting awareness, research funding, and support networks. Economic and social aspects involve access to gluten-free products, food labeling laws, and considerations in schools, workplaces, and travel. Cultural and culinary adaptations have evolved to accommodate gluten-free diets across diverse cuisines and communities. Medical education, clinical guidelines, and research consortia continue to shape diagnostic and therapeutic standards while patient advocacy groups influence policy, reimbursement, and quality-of-life initiatives.
Hippocrates Samuel Gee Giovanni Battista Morgagni Andreas Vesalius William Osler Thomas Addison Friedrich Wegener Jean-Martin Charcot Claude Bernard Rudolf Virchow Camillo Golgi Paul Ehrlich Robert Koch Louis Pasteur Alexander Fleming Howard Florey Ernest Starling Alfred P. Sloan William Osler James Paget Edward Jenner Ignaz Semmelweis John Snow Florence Nightingale Avicenna Galen Hippocrates Samuel Hahnemann Karl Landsteiner Emil von Behring Niels Ryberg Finsen Barry Marshall Robin Warren Christiaan Barnard Jonas Salk Albert Sabin Rosalind Franklin James Watson Francis Crick Barbara McClintock Gregor Mendel Thomas Hunt Morgan Hugo de Vries Sewall Wright Theodosius Dobzhansky Santiago Ramón y Cajal Antoni van Leeuwenhoek Louis Leakey Jane Goodall David Attenborough Jacques Cousteau Neil Armstrong Yuri Gagarin Niels Bohr Albert Einstein Isaac Newton Galileo Galilei Johannes Kepler Nicolaus Copernicus Marie Curie Ada Lovelace Alan Turing Grace Hopper Tim Berners-Lee Steve Jobs Bill Gates Elon Musk
Category:Gastrointestinal diseases